Results suggest that the omega-6 PUFA LA may be protective against PAD, and other omega-6 PUFAs are not associated with PAD incidence, further evidence that omega-6 PUFA-disease relationships should be evaluated by individual fatty acids rather than grouped as total omega-6 PUFAs.
Sarah O. Nomura, Natalie L. Weir, Wei-Hua Guan et al.· Journal of the American Hear...· 0 citations
Routine assessment of GlycA in addition to Lp(a) and hs-CRP may help to identify individuals at particularly increased CVD risk who may benefit from more aggressive preventive therapies.
P. Garg, Wei-Hua Guan, Sarah O. Nomura et al.· Journal of the American Hear...· 0 citations
Ten‐year atherosclerotic cardiovascular disease (ASCVD) risk prediction models include the pooled cohort equations (PCE) and the Predicting Risk of Cardiovascular Disease Events (PREVENT) models. We evaluated the relative contributions of predictors in these models, along with social determinants and emerging biomarker...
Yixin Zhang, Ernst J. Schaefer, Hiroaki Ikezaki et al.· Journal of the American Hear...· 0 citations
Beyond arterial lipid deposition, TRL and Lp(a) converge on inflammatory and vascular remodeling pathways that, under the assumptions of observational mediation analysis, may explain their excess per-particle atherogenicity compared with LDL.
J. Morze, E. Björnson, Michael Y. Mi et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.